Acute hypoxia promote the phosphorylation of tau via ERK pathway

Neuroscience Letters

Volumn 474, Issue 3, 2010, Pages 173-177

  Fang, Hui ^a   Zhang, Li Feng ^a   Meng, Fan Tao ^a   Du, Xin ^a   Zhou, Jiang Ning ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Alzheimer's disease; ERK; Hypoxia; Tau

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN HYPOXIA; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HIPPOCAMPUS; MICROTUBULE; MOUSE; NERVE CELL CULTURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; ANOXIA; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; HUMANS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 77951499897     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.03.037     Document Type: Article

References (24)

1. Biernat J., Gustke N., Drewes G., Mandelkow E.M., Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 1993, 11:153-163.
2. Biernat J., Mandelkow E.M. The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol. Biol. Cell 1999, 10:727-740.
3. Burkhart K.K., Beard D.C., Lehman R.A., Billingsley M.L. Alterations in tau phosphorylation in rat and human neocortical brain slices following hypoxia and glucose deprivation. Exp. Neurol. 1998, 154:464-472.
4. Dawson H.N., Ferreira A., Eyster M.V., Ghoshal N., Binder L.I., Vitek M.P. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell. Sci. 2001, 114:1179-1187.
5. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell. Sci. 2003, 116:1175-1186.
6. Guise S., Braguer D., Carles G., Delacourte A., Briand C. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J. Neurosci. Res. 2001, 63:257-267.
7. Hamdane M., Sambo A.V., Delobel P., Begard S., Violleau A., Delacourte A., Bertrand P., Benavides J., Buee L. Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. J. Biol. Chem. 2003, 278:34026-34034.
8. Huang L.E., Bunn H.F. Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 2003, 278:19575-19578.
9. Huang L.E., Willmore W.G., Gu J., Goldberg M.A., Bunn H.F. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J. Biol. Chem. 1999, 274:9038-9044.
10. Johnson G.V., Jenkins S.M. Tau protein in normal and Alzheimer's disease brain. J. Alzheimers Dis. 1999, 1:307-328.
11. Kosik K.S., Joachim C.L., Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:4044-4048.
12. Liu C., Shi Y., Du Y., Ning X., Liu N., Huang D., Liang J., Xue Y., Fan D. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. Exp. Cell Res. 2005, 309:410-418.
13. Perry G., Roder H., Nunomura A., Takeda A., Friedlich A.L., Zhu X., Raina A.K., Holbrook N., Siedlak S.L., Harris P.L., Smith M.A. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 1999, 10:2411-2415.
14. Probst A., Gotz J., Wiederhold K.H., Tolnay M., Mistl C., Jaton A.L., Hong M., Ishihara T., Lee V.M., Trojanowski J.Q., Jakes R., Crowther R.A., Spillantini M.G., Burki K., Goedert M. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 2000, 99:469-481.
15. Smith C.B., Bowen D.M. Soluble proteins in normal and diseased human brain. J. Neurochem. 1976, 27:1521-1528.
16. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 2002, 156:1051-1063.
17. Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L.E., Song W. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18727-18732.
18. Sung S.M., Jung D.S., Kwon C.H., Park J.Y., Kang S.K., Kim Y.K. Hypoxia/reoxygenation stimulates proliferation through PKC-dependent activation of ERK and Akt in mouse neural progenitor cells. Neurochem. Res. 2007, 32:1932-1939.
19. Takei Y., Teng J., Harada A., Hirokawa N. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J. Cell Biol. 2000, 150:989-1000.
20. Wang R., Zhang Y.W., Zhang X., Liu R., Hong S., Xia K., Xia J., Zhang Z., Xu H. Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J. 2006, 20:1275-1277.
21. Weingarten M.D., Lockwood A.H., Hwo S.Y., Kirschner M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U.S.A. 1975, 72:1858-1862.
22. Wood J.G., Mirra S.S., Pollock N.J., Binder L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc. Natl. Acad. Sci. U.S.A. 1986, 83:4040-4043.
23. Yoon S.O., Shin S., Mercurio A.M. Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer Res. 2005, 65:2761-2769.
24. Zhang X., Zhou K., Wang R., Cui J., Lipton S.A., Liao F.F., Xu H., Zhang Y.W. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 2007, 282:10873-10880.